Cormorant Asset Management »

SPDR S&P Biotech shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $122M 1.0M 121.93
2022-06-30 $33M 450k 74.27
2021-03-31 $136M 1.0M 135.65
2020-12-31 $211M 1.5M 140.78
2020-09-30 $56M 500k 111.43
2020-06-30 $56M 500k 111.95
2019-12-31 $48M 500k 95.11
2019-09-30 $31M 400k 76.25
2019-06-30 $79M 900k 87.71
2019-03-31 $84M 925k 90.54

More positions owned by Cormorant Asset Management

Praxis Precision Medicines I Com New (PRAX)
Bridgebio Oncology Therapeut Com New (BBOT)
Abivax Sa Sponsored Ads (ABVX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Eyepoint Com New (EYPT)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Series Trust State Street Spd Put Option (XBI)
Rapport Therapeutics (RAPP)
Bridgebio Pharma (BBIO)
Bright Minds Biosciences Com New (DRUG)
Edgewise Therapeutics (EWTX)
Olema Pharmaceuticals (OLMA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Insmed Com Par $.01 (INSM)
Engene Holdings (ENGN)

View all positions for Cormorant Asset Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech